Brief: Hoth Therapeutics Accepted Into Nvidia Connect Program, Expanding Its Ai And Accelerated Computing Capabilities
Brief: Hoth Therapeutics Launches VA-Backed Study Of Novel GDNF Weight Loss Therapy Targeting Obesity And Fatty Liver Disease
U.S. STOCKS ON THE MOVE-RBB Bancorp, Hologic, Eversource
U.S. STOCKS ON THE MOVE-RBB Bancorp, Hologic, Eversource
U.S. STOCKS ON THE MOVE-Lockheed Martin, Truist Financial, Reddit
Hoth Therapeutics rises after FDA's orphan drug tag for rare tumor drug
Brief: Hoth Therapeutics Reports FDA Orphan Drug Designation and Strong Preclinical Data for HT-KIT in Rare c-KIT-Driven Cancers
U.S. STOCKS ON THE MOVE-Datadog, First Majestic, Best Buy
U.S. STOCKS ON THE MOVE-United Rentals, Dell, Datadog
U.S. STOCKS ON THE MOVE-Ford Motor, CVS Health, Phillips 66
Hoth Therapeutics rises as it expands AI push with Nvidia licenses
Brief: Hoth Therapeutics Expands Artificial Intelligence Initiative, Selects NVIDIA AI Enterprise Platform
Brief: Hoth Therapeutics Issues Update- HT-001, HT-KIT, VA Obesity Program Drive Strongest Position in Company History
U.S. STOCKS ON THE MOVE-Vaccine makers, NextDecade, Alaska Air Group
Hoth Therapeutics climbs on $1 million crypto reserve plan
U.S. STOCKS ON THE MOVE-Warner Bros Discovery, Cocrystal Pharma, Prenetics Global
U.S. STOCKS ON THE MOVE-Lennox, Camtek, J.M. Smucker
Hoth Therapeutics climbs on $1 mln crypto reserve plan
Brief: Hoth Therapeutics Approved Expansion Of Treasury Reserve Strategy To Include Ethereum And Solana